In a trial of patients with T2DM and a BMI of 27 kg/m2 or greater being treated with semaglutide injection for weight loss, clinically significant hypoglycemia (plasma glucose less than 54 mg/dL) was reported in 6.2% of semaglutide-treated patients versus 2.5% of placebo-treated patients
IV delivery places the administered dose into systemic circulation, but that does not mean 100% enters target cells, remains intact, reaches a specific organ, or produces a clinical benefit
The body can use the protein to help build muscle and rebuild tissue
10.2147/ijn.s377600 49 LiangW.ZhouC.DengY.FuL.ZhaoJ.LongH.et al (2024)
It's grounded in a cultural narrative that continues to treat weight, uniquely among chronic conditions, as a matter of willpower rather than physiology
And on the flip side, I also feel [that] patients are more obsessively using diet products or health trackers," she says